Torres-Olivieri Andrs, Pelegrina-Perez Tatiana C, Delgado Lorena, Vidal Natalia, Toro-Pagan Joel
From the Department of Surgery, University of Puerto Rico School of Medicine, San Juan, PR.
Plast Reconstr Surg Glob Open. 2025 Apr 14;13(4):e6686. doi: 10.1097/GOX.0000000000006686. eCollection 2025 Apr.
The use of an inferior breast pole dermal flap for implant support in breast reconstruction is a reconstructive option with particularly favorable results in patients with macromastia and/or ptosis. The purpose of this study was to analyze the outcomes of Hispanic patients and compare them with those in the existing literature.
This observational study was conducted using a single surgeon's database. The study included female patients with macromastia and/or ptosis who underwent skin-sparing breast reconstruction using an inferior dermal flap for implant support. Variables obtained included patient demographics, history of chemotherapy or radiotherapy, degree of ptosis, brassiere size, size of initial tissue expander, final implant size, number of expansions, and complications.
A total of 202 women met the inclusion criteria; 136 underwent bilateral reconstruction and 66 underwent unilateral reconstruction. All patients underwent immediate reconstruction, 180 (89.1%) underwent 2-stage reconstruction, and 22 (10.9%) underwent 1-stage reconstruction. No significant trend was observed among those who went directly to implant and those who had tissue expander placement. The majority of patients had ptosis grade III (47.8%). Between 2017 and 2023, there were a total of 22 complications (10.9%), with the most common being infection (3.5%). Forty-two patients received radiotherapy, of which only 5 developed complications.
Breast reconstruction with an inferior breast pole dermal flap is a safe and feasible option, with minimal complications in Hispanic patients with ptosis and macromastia.
使用乳房下极真皮瓣进行乳房重建术中的植入物支撑是一种重建选择,对于巨乳症和/或乳房下垂患者尤其具有良好效果。本研究的目的是分析西班牙裔患者的手术结果,并与现有文献中的结果进行比较。
本观察性研究使用了单一外科医生的数据库。该研究纳入了患有巨乳症和/或乳房下垂的女性患者,她们接受了保留皮肤的乳房重建术,使用乳房下真皮瓣进行植入物支撑。获取的变量包括患者人口统计学信息、化疗或放疗史、乳房下垂程度、胸罩尺寸、初始组织扩张器尺寸、最终植入物尺寸、扩张次数和并发症。
共有202名女性符合纳入标准;136例行双侧重建,66例行单侧重建。所有患者均接受即刻重建,180例(89.1%)接受两阶段重建,22例(10.9%)接受一阶段重建。在直接植入假体的患者和放置组织扩张器的患者之间未观察到显著趋势。大多数患者为Ⅲ级乳房下垂(47.8%)。2017年至2023年期间,共有22例并发症(10.9%),最常见的是感染(3.5%)。42例患者接受了放疗,其中只有5例出现并发症。
对于患有乳房下垂和巨乳症的西班牙裔患者,使用乳房下极真皮瓣进行乳房重建是一种安全可行的选择,并发症极少。